Mitochondria-targeted CoQ10 loaded PLGA-b-PEG-TPP nanoparticles: Their effects on mitochondrial functions of COQ8B HK-2 cells-Reference-Cited by-同舟云学术

Mitochondria-targeted CoQ10 loaded PLGA-b-PEG-TPP nanoparticles: Their effects on mitochondrial functions of COQ8B HK-2 cells

Published:2022-04 Issue: Volume:173 Page:22-33
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Sena Ozbay Hamide,Yabanoglu-Ciftci Samiye,Baysal Ipek,Gultekinoglu Merve,Can Eylem Cemil,Ulubayram Kezban,Nemutlu Emirhan,Topaloglu Rezan,Ozaltin Fatih

Funder

Hacettepe University

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference30 articles.

1. Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies;Ozaltin;Pediatr. Nephrol.,2014

2. Mutations in COQ8B (ADCK4) found in patients with steroid-resistant nephrotic syndrome alter COQ8B function;Vazquez Fonseca;Hum. Mutat.,2018

3. ADCK4 mutations promote steroid-resistant nephrotic syndrome through CoQ10 biosynthesis disruption;Ashraf;J. Clin. Invest.,2013

4. ADCK4-Associated Glomerulopathy Causes Adolescence-Onset FSGS;Korkmaz;J. Am. Soc. Nephrol.,2016

5. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment;Atmaca;Pediatr. Nephrol.,2017

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanodrug Delivery Systems for Myasthenia Gravis: Advances and Perspectives;Pharmaceutics;2024-05-11

2. The relationship between kidney disease and mitochondria: a bibliometric study;Renal Failure;2024-01-23

3. Coenzyme Q biochemistry and biosynthesis;Trends in Biochemical Sciences;2023-05

4. Robust intervention for oxidative stress-induced injury in periodontitis via controllably released nanoparticles that regulate the ROS-PINK1-Parkin pathway;Frontiers in Bioengineering and Biotechnology;2022-12-15

5. The Anti-Cancer Effects of Mitochondrial-Targeted Triphenylphosphonium–Resveratrol Conjugate on Breast Cancer Cells;Pharmaceuticals;2022-10-15